Basal-like carcinoma - Wikipedia
Luminal B Breast Cancer | Breast Cancer Trials
Breast Cancer Subtypes And Prognosis | BCTT
Revisiting the impact of age and molecular subtype on overall survival after radiotherapy in breast cancer patients | Scientific Reports
Relapse-free survival in luminal A-like versus luminal B-like breast... | Download Scientific Diagram
Disease-free survival curves of luminal type A and B breast cancer. | Download Scientific Diagram
Frontiers | High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study
Luminal B Breast Cancer: Symptoms, Diagnosis, and Treatment
Breast Cancer Subtypes And Prognosis | BCTT
Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer - ScienceDirect
Long-term outcomes of non-metastatic breast cancer patients by molecular subtypes | BMC Women's Health | Full Text
Overall survival depends on tumor subtype and systemic treatment. a... | Download Scientific Diagram
Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer - ScienceDirect
Breast cancer-specific survival by body mass index categories for... | Download Scientific Diagram
The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score - Yang - 2023 - Cancer Medicine - Wiley Online Library
Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy | Scientific Reports
Luminal B Breast Cancer: Symptoms, Diagnosis, and Treatment
Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer
:max_bytes(150000):strip_icc()/GettyImages-1164234982-17a305f7dbaf4f4fb29ca25003cde65b.jpg "Luminal A Breast Cancer: Causes, Diagnosis, and Treatment")
Luminal A Breast Cancer: Causes, Diagnosis, and Treatment
Ki‑67 index value and progesterone receptor status can predict prognosis and suitable treatment in node‑negative breast cancer patients with estrogen receptor‑positive and HER2‑negative tumors
IJMS | Free Full-Text | How to Predict Metastasis in Luminal Breast Cancer? Current Solutions and Future Prospects
Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden | BMC Cancer | Full Text
Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study | Scientific Reports
Five-year survival in luminal breast cancer patients: relation with intratumoral activity of proteasomes - Sereda - Translational Breast Cancer Research
